Neuropeptides
Volume 41, Issue 1 , Pages 59-63 , February 2007

Diurnal and seasonal variation of cholecystokinin peptides in humans

  • Kristina Lundberg

      Affiliations

    • Department of Neuroscience and Locomotion, Psychiatry Section, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden
    • ,
  • Ann Josefsson

      Affiliations

    • Department of Molecular and Clinical Medicine, Division of Obstetrics and Gynaecology, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden
    • ,
  • Conny Nordin

      Affiliations

    • Department of Neuroscience and Locomotion, Psychiatry Section, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 13 22 38 64; fax: + 46 13 22 33 92.

Received 19 June 2006 ,Accepted 15 September 2006.

References 

  1. Abelson JL. Cholecystokinin in psychiatric research: a time for cautious excitement. J. Psychiatr. Res. 1995;29:389–396
  2. Boden P, Hill RG. Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. Br. J. Pharmacol. 1988;94:246–252
  3. Bradwejn J. Neurobiological investigations into the role of cholecystokinin in panic disorder. J. Psychiatry Neurosci. 1993;18:178–188
  4. Crespi F. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naïve rats, Methods Find. Exp. Clin. Pharmacol. 1998;20:679–697
  5. Eklundh T, Gunnarsson T, Örnhagen H, Nordin C. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure. Aviat. Space Environ. Med. 2000;71:1131–1136
  6. Gunnarsson T, Eklundh T, Eriksson M, Sjöberg S, Nordin C. Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects lumbar-punctured without preceding strict bed-rest. J. Neural Transm. 1999;106:275–282
  7. Hornnes PJ, Kühl C, Holst JJ, Lauritsen KB, Rehfeld JF, Schwartz TW. Simultaneous recording of the gastro-entero-pancreatic hormonal peptide response to food in man. Metabolism. 1980;29:777–779
  8. Hösing VG, Schirmacher A, Kuhlenbaumer G, Freitag C, Sand P, Schlesiger C, et al. Cholecystokinin- and cholecystokinin-B-reeptor gene polymorphisms in panic disorder. J. Neural Transm. 2004;68:147–156
  9. Kõks S, Männistö PT, Bourin M, Shlik J, Vasar V, Vasar E. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations. J. Psychiatry Neurosci. 2000;25:33–42
  10. MacVicar BA, Kerrin JP, Davison JS. Inhibition of synaptic transmission in the hippocampus by cholecystokinin (CCK) and its antagonism by a CCK-analog (CCK27-33). Brain Res. 1987;406:130–135
  11. Nicholson SA, Adrian TE, Bacarese-Hamilton AJ, Gillham B, Jones MT, Bloom SR. 24-hour variation in content and release of hypothalamic neuropeptides in the rat. Regul. Pept. 1983;7:385–397
  12. Nomoto S, Ohta M, Kanai S, Yoshida Y, Takiguchi S, Funakoshi A, et al. Absence of the cholecystokinin-A receptor deteriorates homeostasis of body temperature in response to changes in ambient temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;287:R556–R561
  13. Passaro E, Debas H, Oldendorf W, Yamada T. Rapid appearance of intraventricularly neuropeptides in the peripheral circulation. Brain Res. 1982;241:335–340
  14. Rehfeld JF, Kruse-Larsen C. Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity. Brain Res. 1978;155:19–26
  15. Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin. Chem. 1998;44:991–1001
  16. Rehfeld JF. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul. Pept. 1998;78:31–39
  17. Rehfeld JF. Cholecystokinin. Best. Pract. Res. Clin. Endocrinol. Metab. 2004;18:569–586
  18. van den Pol AN, Tsujimoto KL. Neurotransmitters of the hypothalamic suprachiasmatic nucleus: immunocytochemical analysis of 25 neuronal antigens. Neuroscience. 1985;15:1049–1086
  19. Wang Z, Wasslink T, Andreasen N, Crowe RR. Possible association of a cholecystokinin promoter variant in schizophrenia. Am. J. Med. Genet. 2002;114:479–482

☆ This study was supported by Grants from the County Council of Östergötland, Sweden.

PII: S0143-4179(06)00114-4

doi: 10.1016/j.npep.2006.09.049

Neuropeptides
Volume 41, Issue 1 , Pages 59-63 , February 2007

Article Tools

* Image Usage & Resolution